Miranda P S D, Lannes-Costa P S, Pimentel B A S, Silva L G, Ferreira-Carvalho B T, Menezes G C, Mattos-Guaraldi A L, Hirata R, Mota R A, Nagao P E
Laboratory of Molecular Biology and Physiology of Streptococci, Institute of Biology Roberto Alcantara Gomes, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Institute of Microbiology Paulo de Góes, Rio de Janeiro Federal University, Rio de Janeiro, Brazil.
Lett Appl Microbiol. 2018 Sep;67(3):235-243. doi: 10.1111/lam.13015. Epub 2018 Jul 10.
Streptococcus agalactiae is among the most relevant aetiologic agent of bovine clinical and subclinical mastitis, a major problem for the dairy industry. In Brazil, clonal diversity, capsular typing and multidrug resistance profiles of S. agalactiae related to human and bovine infections need further investigation. Presently, S. agalactiae isolates of bovine subclinical mastitis, from Brazilian Northeastern region, were submitted to capsular and pulsed-field gel electrophoresis (PFGE)-typing, antimicrobial susceptibility and assays of biofilm formation at different time incubation and pH levels. Sixteen bovine isolates were characterized by polymerase chain reaction assay as S. agalactiae capsular type II (CTII) and classified by PFGE in A1/A2 (n = 06), B1/B2 (n = 06), C (n = 03) and D (n = 01) patterns. Bovine S. agalactiae CTII strains were classified as 25% multidrug-resistant (MDR) with susceptibility to penicillin, linezolid and vancomycin. Biofilm formation on abiotic surface was strain- and time-dependent with significantly higher rates at pH 6·5. In conclusion, S. agalactiae capsular type II isolates recovered from bovine subclinical mastitis produced different pH-dependent biofilm levels. Our findings suggest that biofilm production is modulated by environmental factors and provides S. agalactiae advantageous in colonizing mammary gland during mastitis development, including MDR strains.
Streptococcus agalactiae is among the most relevant aetiologic agent of bovine clinical and subclinical mastitis, a major problem for the dairy industry. The disease may cause significant economic loss due to decreased production and milk quality and increased use of medicaments. Presently, data demonstrated that biofilm formation favours the establishment of infectious process in health mammary tissue by S. agalactiae and emphasizes that an acidic pH promotes adhesion by biofilm-forming bacterial strains. S. agalactiae strains (25%) showed resistance to tetracycline, azithromycin, erythromycin and clindamycin, and consequently were classified as multidrug-resistant strains.
无乳链球菌是牛临床和亚临床乳腺炎最主要的病因之一,这是乳制品行业的一个重大问题。在巴西,与人类和牛感染相关的无乳链球菌的克隆多样性、荚膜分型和多重耐药性谱需要进一步研究。目前,从巴西东北部地区收集的牛亚临床乳腺炎无乳链球菌分离株,进行了荚膜和脉冲场凝胶电泳(PFGE)分型、抗菌药敏试验以及在不同孵育时间和pH水平下的生物膜形成测定。通过聚合酶链反应测定,16株牛分离株被鉴定为无乳链球菌荚膜II型(CTII),并通过PFGE分为A1/A2(n = 06)、B1/B2(n = 06)、C(n = 03)和D(n = 01)型。牛无乳链球菌CTII菌株中有25%被归类为多重耐药(MDR),对青霉素、利奈唑胺和万古霉素敏感。在非生物表面形成生物膜具有菌株和时间依赖性,在pH 6.5时发生率显著更高。总之,从牛亚临床乳腺炎中分离出的无乳链球菌荚膜II型菌株产生了不同的pH依赖性生物膜水平。我们的研究结果表明,生物膜的产生受环境因素调节,这使得无乳链球菌在乳腺炎发展过程中,包括MDR菌株,在乳腺定植方面具有优势。
无乳链球菌是牛临床和亚临床乳腺炎最主要的病因之一,这是乳制品行业的一个重大问题。由于产量和牛奶质量下降以及药物使用增加,该疾病可能导致重大经济损失。目前,数据表明生物膜的形成有利于无乳链球菌在健康乳腺组织中建立感染过程,并强调酸性pH促进形成生物膜的细菌菌株的黏附。无乳链球菌菌株(25%)对四环素、阿奇霉素、红霉素和克林霉素耐药,因此被归类为多重耐药菌株。